🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/12/2014 | 54,67 | 55,21 | 54,63 | 54,83 | +0,44% | 1,06% | 5.293.448 |
| 23/12/2014 | 56,00 | 56,30 | 54,42 | 54,59 | -2,97% | 3,36% | 14.845.339 |
| 22/12/2014 | 56,41 | 56,83 | 55,87 | 56,26 | -1,04% | 1,71% | 10.491.004 |
| 19/12/2014 | 56,54 | 57,16 | 56,31 | 56,85 | +1,02% | 1,50% | 18.208.162 |
| 18/12/2014 | 55,91 | 56,28 | 55,43 | 56,28 | +2,34% | 1,52% | 14.000.651 |
| 17/12/2014 | 54,44 | 55,15 | 53,97 | 54,99 | +1,46% | 2,17% | 13.271.662 |
| 16/12/2014 | 54,36 | 55,62 | 54,18 | 54,20 | -0,26% | 2,65% | 11.752.272 |
| 15/12/2014 | 55,17 | 55,40 | 54,20 | 54,34 | -1,33% | 2,18% | 12.759.610 |
| 12/12/2014 | 56,42 | 56,92 | 55,07 | 55,08 | -2,73% | 3,28% | 12.702.179 |
| 11/12/2014 | 57,04 | 57,81 | 56,48 | 56,62 | -1,07% | 2,33% | 11.857.177 |
| 10/12/2014 | 57,37 | 57,75 | 56,97 | 57,23 | -0,05% | 1,36% | 13.889.878 |
| 09/12/2014 | 56,68 | 57,39 | 56,06 | 57,26 | -3,02% | 2,34% | 19.679.554 |
| 08/12/2014 | 58,37 | 59,35 | 58,19 | 59,05 | +0,63% | 1,99% | 11.941.646 |
| 05/12/2014 | 58,23 | 58,94 | 58,03 | 58,67 | +0,94% | 1,56% | 11.708.046 |
| 04/12/2014 | 57,74 | 58,57 | 57,74 | 58,13 | +0,56% | 1,44% | 7.456.101 |
| 03/12/2014 | 57,98 | 58,14 | 57,55 | 57,81 | -0,33% | 1,02% | 10.197.564 |
| 02/12/2014 | 57,85 | 58,19 | 57,52 | 58,00 | +0,43% | 1,15% | 6.755.408 |
| 01/12/2014 | 57,63 | 58,51 | 57,52 | 57,75 | +0,20% | 1,72% | 8.671.257 |
| 28/11/2014 | 56,97 | 58,08 | 56,97 | 57,63 | +1,09% | 1,96% | 6.505.355 |
| 26/11/2014 | 56,97 | 57,03 | 56,63 | 57,01 | +0,69% | 0,70% | 6.582.069 |
| 25/11/2014 | 56,60 | 56,93 | 56,42 | 56,62 | +0,15% | 0,89% | 10.824.373 |
| 24/11/2014 | 57,07 | 57,07 | 56,29 | 56,54 | -0,69% | 1,37% | 8.895.424 |
| 21/11/2014 | 57,19 | 57,27 | 56,61 | 56,93 | +0,47% | 1,15% | 11.800.899 |
| 20/11/2014 | 56,50 | 56,68 | 56,16 | 56,66 | -0,44% | 0,91% | 7.064.673 |
| 19/11/2014 | 56,90 | 56,99 | 56,42 | 56,91 | -0,42% | 1,01% | 7.655.011 |
| 18/11/2014 | 56,77 | 57,38 | 56,44 | 57,15 | +0,72% | 1,65% | 8.030.824 |
| 17/11/2014 | 56,98 | 57,16 | 56,59 | 56,74 | +0,66% | 0,99% | 8.982.722 |
| 14/11/2014 | 56,52 | 56,82 | 56,08 | 56,36 | -0,79% | 1,32% | 7.472.869 |
| 13/11/2014 | 56,77 | 57,20 | 56,47 | 56,81 | +0,39% | 1,29% | 6.965.951 |
| 12/11/2014 | 56,56 | 56,82 | 56,39 | 56,59 | -0,10% | 0,76% | 6.988.902 |